EUVIMEDOpdag EUVIMED
Crossref

Prospective evaluation of fluorine-18 fluorodeoxyclucose positron emission tomography in breast cancer for staging of the axilla related to surgery and immunocytochemistry

C I Utech, C S Young, P F Winter

European Journal of Nuclear Medicine · 1996-12 · 23 (12) · 1588-1593

DOI: 10.1007/bf01249621 ↗

At a glance

Journal article in European Journal of Nuclear Medicine, 1996-12. Written by C I Utech and 2 co-authors. Institution: University of Illinois College of Medicine at Peoria, Peoria, Illinois, USA. Major MEDLINE topics: Fluorine Radioisotopes, Tomography, Emission-Computed. Cited 130 times so far (Crossref); 28 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The noninvasive staging of axillary lymph nodes for metastases is investigated in patients with breast cancer prior to surgery by positron emission tomography (PET) with fluorine-18-fluoro-2-deoxy-d-glucose (18F-FDG). In 124 patients with newly diagnosed breast cancer, whole-body PET was performed to determine the average differential uptake ratio (DUR) of 18F-FDG in the axillary lymph nodes. Results were correlated with the number of the dissected lymph nodes, size of the primary tumor, tumor type, tumor grade, estrogen and progesterone receptors, DNA ploidy, and the proportion of cells in the synthetic phase of the cell cycle (S-phase). In this prospective study of 124 patients with breast carcinoma, PET correctly categorized all 44 tumor-positive axillary lymph nodes, a sensitivity of 100%. Sixty tumor-negative axillary lymph nodes were negative by PET and 20 tumor-negative axillary lymph nodes were positive by PET. No false-negative PET findings were encountered. A weak correlation was found between DUR and tumor size as well as between DUR and the S-phase of the tumor. In patients with breast carcinoma, 18F-FDG PET can be of value in evaluating axillary lymph nodes for metastatic involvement prior to surgery. It is of particular importance that no false-negative PET findings were encountered, and axillary lymph node dissection might not be necessary in patients without axillary uptake by PET. The DUR of the positive axillary lymph nodes seems to bear a relationship with some of the purported prognostic parameters of the primary tumor.

Subjects

MeSH terms (MEDLINE)

Fluorine RadioisotopesTomography, Emission-ComputedAxillaBreast NeoplasmsDeoxyglucoseFemaleFluorodeoxyglucose F18HumansLymph Node ExcisionLymph NodesLymphatic MetastasisMiddle AgedNeoplasm StagingProspective StudiesSensitivity and Specificity

Substances

Fluorine RadioisotopesFluorodeoxyglucose F18Deoxyglucose

Authors and institutions

  • University of Illinois College of Medicine at Peoria, Peoria, Illinois, USA.

Cite

APA

Utech, C. I., Young, C. S., & Winter, P. F. (1996). Prospective evaluation of fluorine-18 fluorodeoxyclucose positron emission tomography in breast cancer for staging of the axilla related to surgery and immunocytochemistry. European Journal of Nuclear Medicine, 23(12), 1588-1593. https://doi.org/10.1007/bf01249621

Vancouver

Utech CI, Young CS, Winter PF. Prospective evaluation of fluorine-18 fluorodeoxyclucose positron emission tomography in breast cancer for staging of the axilla related to surgery and immunocytochemistry. European Journal of Nuclear Medicine. 1996;23(12):1588-1593. doi:10.1007/bf01249621

BibTeX
@article{Utech1996,
  author = {Utech, C I and Young, C S and Winter, P F},
  title = {Prospective evaluation of fluorine-18 fluorodeoxyclucose positron emission tomography in breast cancer for staging of the axilla related to surgery and immunocytochemistry},
  journal = {European Journal of Nuclear Medicine},
  year = {1996},
  volume = {23},
  number = {12},
  pages = {1588--1593},
  doi = {10.1007/bf01249621}
}
Start for free →